Processa Pharmaceuticals (PCSA) Change in Inventory (2012 - 2015)
Processa Pharmaceuticals' (PCSA) quarterly Change in Inventory came in at $15129.0 in Q4 2015, up 189.64% on a YoY basis from $5223.4 in Q4 2014, and up 135.71% quarter-over-quarter from -$42367.0 in Q3 2015.
Analysis
Processa Pharmaceuticals (PCSA) Change in Inventory (2012 - 2015) Analysis & Trends
Processa Pharmaceuticals (PCSA) has reported Change in Inventory for 4 consecutive years, with $15129.0 the latest figure, recorded in Q4 2015.
- For the quarter ending Q4 2015, Change in Inventory rose 189.64% year-over-year to $15129.0; the trailing twelve-month figure through Dec 2015 stood at -$7065.0 (up 90.33% YoY), and the FY2015 full-year result was -$7065.0, up 90.33% from the prior year.
- Change in Inventory advanced to $15129.0 in Q4 2015 per PCSA's latest filing, from -$42367.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $60883.0 in Q4 2013 and bottomed at -$135732.0 in Q2 2013.
- Historically, Change in Inventory has averaged -$11699.6 across 4 years, with a median of -$2502.0 in 2012.
- The sharpest annual moves came in 2013 and 2015: Change in Inventory soared 6618.52% in 2013, then slumped 866.68% in 2015.
- Over 4 years, Change in Inventory stood at -$934.0 in 2012, then jumped by 6618.52% to $60883.0 in 2013, then tumbled by 127.72% to -$16878.0 in 2014, then surged by 189.64% to $15129.0 in 2015.
- According to Business Quant data, Change in Inventory over the past three periods registered $15129.0, -$42367.0, and -$4070.0 for Q4 2015, Q3 2015, and Q2 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 11.88 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 17.70 Mn |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 15,129.00 |
| Sep 30, 2015 | -42,367.00 |
| Jun 30, 2015 | -4,070.00 |
| Mar 31, 2015 | 24,243.00 |
| Dec 31, 2014 | -16,878.00 |
| Sep 30, 2014 | 5,526.00 |
| Jun 30, 2014 | 57,503.00 |
| Mar 31, 2014 | -119,236.00 |
| Dec 31, 2013 | 60,883.00 |
| Sep 30, 2013 | -8,629.00 |
| Jun 30, 2013 | -135,732.00 |
| Mar 31, 2013 | -13,891.00 |
| Dec 31, 2012 | -934.00 |
| Sep 30, 2012 | 14,659.00 |